(44) has shown that apigenin can improve the symptoms of arthritis in CFA rats and its anti-inflammatory mechanism may be mediated by reducing the expression of cytokines (IL-1, IL-6 and TNF-) and inhibiting the P2X7/NF-B signaling pathway
Also, these findings in healthy adults are unable to be generalized to individuals with acute or chronic health conditions associated with reduced glutathione status, including metabolic syndrome, diabetes, neurodegenerative disease, cancer, HIV/AIDS, pulmonary disease, and/or acute infection
IV therapy allows for a higher concentration of glutathione to be rapidly delivered to the cells, offering more immediate and noticeable benefits
Its disadvantage relative to newer hair-focused peptides is the lack of dedicated clinical trials for hair as a primary endpoint
Bhattacharyya, S., Saha, S., Giri, K., Lanza, I